<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To summarize the data of autologous peripheral stem cell transplantation (APBSCT) for 49 hematological <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Forty-nine patients, 18 with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) 10 <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>(ALL), 14 <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>(MM), 6 non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>(NHL) and 1 <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>(<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) received APBSCT were retrospectively analyzed </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Comparing to conventional chemotherapy, APBSCT can prolong the patients' disease-free survival(DFS) and overall survival (OS) </plain></SENT>
<SENT sid="3" pm="."><plain>The 3 and 5-year OS rates were 74.78% and 83.33% for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>/NHL; 38% and 19% for MM; 40% and 0 for ALL, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The time of hematopoietic reconstitution was influenced by G-CSF administration significantly </plain></SENT>
<SENT sid="5" pm="."><plain>The mean time of neutrophil recovering to 0.5 x 10(9)/L after APBSCT was +17.7 days in no G-CSF group, and +11.14 days in G-CSF group </plain></SENT>
<SENT sid="6" pm="."><plain>Up to now, of the 49 patients, no APBSCT related <z:hpo ids='HP_0011420'>death</z:hpo> occur, 23 have died and 22 of them died of relapse </plain></SENT>
<SENT sid="7" pm="."><plain>The most common transplantation related complications were <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> and hypopotassemia, <z:hpo ids='HP_0000001'>all</z:hpo> of which can be cured by proper treatment </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: APBSCT can be safely performed in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
</text></document>